Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034.
Clinical trial NCT02315638 · TERMINATED
Trial details
- NCT number
- NCT02315638
- Sponsor
- Tacere Therapeutics, Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2014-11-01
- Primary completion
- 2018-09-24
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.